Replies to post #133754 on Biotech Values

[iwfal]

The gross margin on Humira is in the neighborhood of 85%, as far as I can tell. It is almost certainly the highest-margin significant product in ABT’s portfolio.

Ok - agree that is good estimate. It is what I was using in general for branded biologics. Now the other assumption? (What would be a fair split of Gross Profit for mHumira)